Anzeige
Mehr »
Login
Mittwoch, 30.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Desert Gold Ventures: Diese Goldaktie ist ein TOP-Übernahmekandidat
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
252 Leser
Artikel bewerten:
(1)

Digital Health in the Neurology Market worth $167.58 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

JERSEY CITY, N.J., March 19, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Health in the Neurology Market - By Component (Hardware, Software, Services), By End-use (Patients, Providers, Payers, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

InsightAce_Analytic_Logo

According to the latest research by InsightAce Analytic, the Global Digital Health in the Neurology Market is valued at US$36.28 Bn in 2023, and it is expected to reach US$ 167.58 Bn by 2031, with a CAGR of 21.3% during the forecast period of 2024-2031.

Digital Health In Neurology Market Report Scope:

Report Attribute

Specifications

Market Size Value In 2023

USD 36.28 Bn

Revenue Forecast In 2031

USD 167.58 Bn

Growth Rate CAGR

CAGR of 21.3% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Component and End-Use

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea

Competitive Landscape

Neofect, Teladoc, Proteus Digital Health, Akili Labs, AppliedVR, Aural Analytics, BehaVR, BetterHelp, Big Health, Omada Health, Blackrock Neurotech, and AdvancedMD and Other Prominent Players

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2358

Digital health in neurology refers to using eHealth and other digital tools to improve neurological disorders' diagnosis, prognosis, and treatment. Digital health technologies are on the rise in neurology due to several factors: better internet connectivity, more widespread use of smartphones, more expensive healthcare, a greater need for remote patient monitoring services, and easier access to virtual care.

Moreover, the expansion of this market is being propelled in large part by government programs that aim to digitalize healthcare systems worldwide. However, the high costs associated with developing and implementing digital health solutions, as well as potential issues with insurance companies' willingness to cover these costs, make it difficult for neurology providers and patients to have access to these technologies, which could limit the growth of the digital health in neurology market. Digital health in the neurology market is an expansion market that can be facilitated by government initiatives that promote digital health and by regulatory settings that are favorable to this industry, propelling digital health in the neurology industry.

List of Important Players In The Digital Health In Neurology Market:

  • Neofect
  • Teladoc
  • Proteus Digital Health
  • Akili Labs
  • AppliedVR
  • Aural Analytics
  • BehaVR
  • BetterHelp
  • Big Health
  • Biogen
  • Omada Health
  • Blackrock Neurotech
  • AdvancedMD
  • Linus Health
  • Medibio
  • The Echo Group
  • Spring Care Inc.
  • Qualifacts Systems, Inc.
  • Other Prominent Players

Market Dynamics:

Drivers-

A growth in the digital health in neurology market is being propelled by the increasing need for improved healthcare solutions due to the rising global prevalence of neurological disorders like Parkinson's, seizures, and multiple sclerosis. The market is being propelled even further by government initiatives and supportive regulatory frameworks encouraging developing and implementing digital health solutions.

Market expansion is also pushed by the rising adoption and utilization of digital health in neurology solutions, which are being educated and widely known to healthcare providers and patients. As a result, the global market for digital health in neurology continues to expand.

Challenges:

Strict regulations, high costs, and limited technology in developing regions are predicted to be challenges that will reduce the market's growth. There are strict regulatory frameworks in place in several locations that affect the digital health sector of neurology. While these rules are essential for protecting patients' health, they can hinder the development and rollout of innovative digital health solutions in neurology.

Due to a lack of readily available technology in developing economies, the cost of using digital health to treat neurological diseases is currently expensive. Neurological illness treatment is costly, and cutting-edge technologies can drive up the price tag even further. These limitations are expected to limit the expansion of the digital health market in neurology during the next few years.

Regional Trends:

The North American digital health in neurology market is expected to register a large market share in the revenue. It is projected to grow at a high CAGR in the near future. The growing need for digital health in neurology due to several reasons, such as increased spending on healthcare IT, better internet connectivity, new technologies, new businesses, beneficial initiatives by the government, rising smartphone penetration, greater resources and expenditures, and the availability of sufficient digital infrastructure, which is expected to grow the region's digital health in neurology market.

Besides, Asia Pacific has a prominent share of the digital health in the neurology market. They are in high demand due to the strong expansion of the economy, which in turn boosts consumer expenditure on health. Factors contributing to the industry's expansion include improvements in coverage networks, the rising use of smartphones, a growing elderly population, and an alarming increase in neurological disorders, contributing to the region's digital health in neurology. Moreover, the regional market's growth is boosted by the increasing frequency of neurological illnesses, with market participants' growing number of technology developments and business activities driving this growth.

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2358

Recent Developments:

  • In March 2024, Linus Health disclosed the acquisition of Aural Analytics, which provides clinical-grade speech analytics. This agreement includes Aural Analytics' assets, such as advanced technology and intellectual property, within Linus Health's multimodal cognitive evaluation platform. Linus Health expects the acquisition to improve its ability to identify cognitive impairment and develop into the life sciences business.
  • In February 2024, Aptar has signed a multi-year enterprise partnership with Biogen to provide digital health solutions to improve care for patients with neurological and rare disorders. The partnership will use Aptar's skills to help create and operate new and existing digital health solutions around the world. According to the agreement, Biogen will transfer ownership of some solutions to Aptar, which will provide a broad range of services.
  • In February 2024, AppliedVR and Kernel announced a cooperative study to measure the brain impact of virtual reality pain management. AppliedVR is a medical device pioneer creating a revolutionary approach to medicine based on virtual reality. A single-masked sham-controlled strategy was employed in the study to examine physiological measurements and brain activity patterns in individuals with persistent low back pain before, during, and after virtual reality encounters.
  • In Aug 2023, Government funding was awarded to Neofect for the development of an AI-powered digital rehabilitation device. Neofect and the Korea Medical Device Development Foundation (KMDF) had entered into a research and development (R&D) agreement for the creation of digital smart boards for patient rehabilitation utilizing artificial intelligence (AI) technologies.

Segmentation of Digital Health in Neurology Market-

By Component-

  • Software
  • Hardware
  • Services

By End-Use-

  • Patients
  • Providers
  • Payers
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

For More Customization @https://www.insightaceanalytic.com/customisation/2358

Why should buy this report:

  • To receive a comprehensive analysis of the prospects for global Digital Health in Neurology market
  • To receive industry overview and future trends of global Digital Health in Neurology market
  • To analyze the Digital Health in Neurology market drivers and challenges
  • To get information on the Digital Health in Neurology market size value (US$ Mn) forecast till 2031
  • Major Investments, Mergers & Acquisition in global Digital Health in Neurology market industry

Other Related Reports Published by InsightAce Analytic:

Neurovascular Devices or Interventional Neurology Market

Placental Stem Cell Therapy for Neurological Disorders Market

Neuroimmunology Drugs Market

Emerging Mental Health Devices and Platforms Market

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact US:

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS

Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/digital-health-in-the-neurology-market-worth-167-58-bn-by-2031---exclusive-report-by-insightace-analytic-pvt-ltd-302092900.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.